Markets News, Nov. 14, 2025: Stock Indexes End Mixed; Dow Declines for 2nd Straight Day But Ends Week Higher; Bitcoin Sinks to Lowest Level in 6 Months

Major U.S. stock indexes closed mixed Friday, with the Dow posting a weekly gain despite a daily decline, while the Nasdaq erased early losses but ended the week lower amid persistent concerns over tech valuations and the impact of delayed economic data post-government shutdown. Notable corporate movements included Cidara Therapeutics soaring over 100% following a $9.2 billion acquisition by Merck, and Warner Bros. Discovery rising on reports of potential takeover bids. Conversely, StubHub shares plunged 21% after declining to issue forward guidance post-IPO, and Bristol-Myers Squibb dropped on discontinuing a late-stage clinical trial. Meanwhile, Nvidia remained a focal point ahead of upcoming earnings, with analysts expecting strong AI-driven results, while Bitcoin continued its decline, reaching its lowest point since early May.

Analysis

Major U.S. equity indices closed mixed Friday, with the Dow and S&P 500 posting weekly gains despite daily declines, while the Nasdaq ended the week lower. Tech stocks experienced significant intraday volatility, initially dropping 3.5-7% on Thursday due to valuation concerns, though most, excluding Intel, recovered by Friday's close. Expectations for a Federal Reserve rate cut have diminished, with the CME FedWatch tool now indicating a 46% chance, down from 67% last week, potentially influenced by delayed economic data releases post-government shutdown. The 10-year Treasury yield rose to 4.15%, and the U.S. dollar strengthened, while Bitcoin fell to $94,300, its lowest since early May.

Corporate activity saw significant movements, highlighted by Merck's $9.2 billion all-cash acquisition of Cidara Therapeutics (CDTX), representing a 109% premium, to bolster its antiviral pipeline. Warner Bros. Discovery (WBD) shares gained nearly 4% on reports of multiple potential takeover bids. Conversely, StubHub (STUB) plunged 21% after its post-IPO earnings report lacked forward guidance, raising investor uncertainty despite underlying revenue growth. Bristol-Myers Squibb (BMY) dropped 4.1% following the discontinuation of a late-stage clinical trial for its experimental heart treatment, milvexian.

The AI sector remains a key focus, with Nvidia (NVDA) shares closing higher ahead of anticipated "beat and raise" Q3 earnings, driven by strong hyperscale AI spending, though some skepticism about AI investment ROI persists. Micron Technology (MU) surged 4.2% after Morgan Stanley upgraded it to a "top pick," citing robust demand for DDR5 memory chips from AI data centers and a market shortage. DoorDash (DASH) saw a 6% jump on a new apparel delivery partnership with Old Navy, diversifying beyond its core restaurant business. Nike (NKE) faced a nearly 3% decline after Moody's downgraded its debt ratings due to increased competition and cost pressures.

Key Decisions for Investors

• Investors should closely monitor upcoming Nvidia earnings for insights into AI sector growth and potential "beat and raise" scenarios, while also assessing the sustainability of hyperscale AI spending.
• Evaluate M&A targets in sectors like biotech (e.g., Cidara Therapeutics) for potential strategic acquisitions and premiums, and consider media companies like Warner Bros. Discovery for consolidation plays.
• Pay close attention to corporate guidance, as seen with StubHub's post-IPO decline, and assess strategic diversification efforts like DoorDash's expansion into new delivery segments.
• Re-evaluate portfolio interest rate sensitivity given the reduced probability of Fed rate cuts and rising Treasury yields, which could impact growth stock valuations.
• Monitor the ongoing decline in Bitcoin and related crypto assets, as well as the strengthening U.S. dollar and rising oil prices, for their potential impact on risk appetite and corporate earnings.